‫CCTV+: شي يقود الصين نحو تنفيذ تنمية أكثر حفاظًا على البيئة بخطوات راسخة

بكين، 4 يناير 2022 / PRNewswire / — بناءً على توجيه من الرئيس شي جين بينغ، اتخذت الصين خطوات راسخة نحو تنفيذ تنمية اقتصادية واجتماعية أكثر حفاظًا على البيئة في جميع الجوانب بالإضافة إلى متابعة التحديث الذي يتميز بالتناغم بين الإنسان والطبيعة خلال السنة الأولى من فترة الخطة الخمسية الرابعة عشرة (2021-2025) للتنمية الاقتصادية والاجتماعية الوطنية.

كان قطيع الأفيال الآسيوية الذي عاد إلى موطنه المناسب وسط مرافقين من البشر بعد أكثر من 110 يومًا من التجول في مقاطعة يونان بجنوب غرب الصين في معظم أوقات عام 2021 مجرد مثالاً على جهود الصين في الحماية البيئية.

صرّح شي أثناء إلقائه الكلمة الرئيسية عبر رابط الفيديو خلال قمة القادة بالاجتماع الخامس عشر بمؤتمر الأطراف في اتفاقية التنوع البيولوجي ( COP15 ) المُنعقد في مدينة كونمينغ بمقاطعة يونان في 12 أكتوبر 2021 “تُظهر قصة التنقل باتجاه الشمال وعودة قطيع من الأفيال في مقاطعة يونان بجنوب غرب الصين النتائج القوية لمساعينا لحماية الحيوانات البرية. وستواصل الصين دفع التقدم البيئي، بالإضافة إلى الالتزام بتنفيذ فلسفة التنمية الجديدة التي تؤكد على التنمية المبتكرة والمنسقة والخضراء والمفتوحة للجميع، فضلاً عن إضفاء طابع الجمال على الصين”.

كمّا دعا شي خلال القيمة إلى بذل جهود مشتركة لإقامة مجتمع يضم جميع أشكال الحياة على كوكب الأرض، وتوفير عالمًا نظيفًا ورائعًا للجميع.

كمّا أصدر شي خلال جولاته التفقدية في جميع أنحاء الصين في عام 2021 تعليمات لتوجيه التنمية الاقتصادية والاجتماعية الأكثر حفاظًا على البيئة لثاني أكبر اقتصاد في العالم.

في إطار الجهود المبذولة للتصدي لتغير المناخ، والذي يُعد أحد التحديات المشتركة التي تواجهها البشرية، قدّم شي التزامًا رسميًا بأن تتضع الصين هدفًا نحو تحقيق ذروتها في انبعاثات ثاني أكسيد الكربون بحلول عام 2030 وتحقيق الحياد الكربوني بحلول عام 2060.

في عام 2021، أجرى شي تقييمًا لصناعة الطاقة في البلاد، وأصدر توجيهاته خلال زياراته لإحدى الشركات الكيميائية في مدينة يولين بمقاطعة شنشي الشمالية الغربية ومنصة التنقيب في حقل شنغلي للنفط في مدينة دونغ ينغ بمقاطعة شاندونغ الشرقية.

كمّا حث شي خلال مؤتمر العمل الاقتصادي المركزي السنوي في ديسمبر 2021 على إحراز تقدم بخطى ثابته في العمل بشأن حياد الكربون، والذي يقول إنه مطلب طبيعي من أجل تنيمة عالية الجودة.

بلغ معدل تغطية الغابات في الصين أكثر من 23 في المائة في عام 2021، كمّا انخفض استهلاك الطاقة لكل وحدة من الناتج المحلي الإجمالي بنسبة 2.3 في المائة سنويًا خلال الأشهر التسعة الأولى.

الرابط:  https://youtu.be/mm64TSpkfZI

الفيديو –  https://www.youtube.com/watch?v=mm64TSpkfZI

PRODESI plans to finance 500 projects this year

Luanda – At least 500 projects from the 1,022 approved in 2021 at country level start receiving financing as from this year in the framework of the Program to Support Production, Export Diversification and Import Substitution (PRODESI), announced the Secretary of State for Economy, Dalva Ringote.

According to the government official, PRODESI has 732.3 billion Kwanzas in several operational credit lines to ensure the financing of the projects of the pointed sectors by the program such as food, agribusiness, mineral resources and tourism.

The official who was speaking Tuesday in the usual briefing of the Minister of Economy and Planning (MEP) made known that this number of projects to finance might increase due to the volume of the proposals already approved to be financed.

Source: Angola Press News Agency

Covid-19: Angola reports 902 new cases, 251 recoveries

Luanda – At least 902 new cases, three deaths and 251 recovered patients are the balances of the last 24 hours, released on Tuesday by health authorities.

Figures from the daily health bulletin show that 619 cases were diagnosed in Luanda, 53 in Cabinda, 52 in Huambo, 48 in Bié, 32 in Kwanza Sul, 24 in Lunda Norte, 22 in Benguela, 22 in Lunda Sul, 20 in Huila and 10 in Cuando Cubango.

Aged between two months and 88 years, 515 are male and 387 are female patients.

In the last 24 hours, the laboratories processed 3,274 samples, with a daily positivity rate of 27.5 percent.

The deaths were registered in Luanda.

Among those recovered, 221 reside in Luanda, 14 in Huíla, 8 in Bié and 8 in Lunda Sul.

Angola has 84,666 confirmed cases, 65,285 recovered, 1,778 deaths and 17,603 active cases. Of the active cases, seven are critical, 50 serious, 82 moderate, 153 light and 17,311 asymptomatic.

In the treatment centres, 292 patients are hospitalised, while 170 are serving institutional quarantine.

Source: Angola Press News Agency

Minister highlights Lower Cassanje martyrs bravery

Cabinda – The Minister of National Defence and Motherland Veteran, João Ernesto dos Santos, considered Tuesday in Cabinda, the January 4, 1961 as fundamental in the resistance trajectory against colonial occupation and for national independence on November 11, 1975.

During the central commemorative act for the sixty-first anniversary of the Day of the Martyrs of the Colonial Repression, João Ernesto dos Santos, referred that the realization of the act in Cabinda was due to the fact that the region had been a laboratory of “brave guerrillas” during the war of national liberation.

He said it was an act that is registered in Cabinda province, in the locality of Ntó, where the Battle with the same name was fought.

Source: Angola Press News Agency

President João Lourenço addresses press Thursday

Luanda – The President of the Republic, João Lourenço, is due to speak Thursday to reporters of five media outlets, during a press conference.

The information was released on Tuesday by the Presidency of the Republic’s Facebook page, saying that it would be the resumption of the presidential initiative unveiled in January 2018.

That year there was a first meeting in the Gardens of the Presidential Palace between the Head of State and the press, which was represented by hundreds of journalists.

Within the framework of that programme, the President of the Republic spoke successively at a second wide-ranging meeting at the end of the same year, and later granted targeted interviews, exclusively at times, and in shared format at others, as happened with the weekly newspaper Novo Jornal and Televisão Pública de Angola.

This time, five media outlets will have the opportunity to ask the President of the Republic direct questions, and other media outlets will do so on future occasions.

Source: Angola Press News Agency

Angola issues IDs in 310 identification posts in and out of country

Luanda – At least 26 Identity Card posts are operating in the Diplomatic and Consular Missions of Angola in the Diaspora plus the 284 posts in the country making a total of 310 posts.

According to the Ministry of Justice and Human Rights that advances the information, since 05 January 1976 up to date were processed 17.5 million processes of Identity Card (ID).

In a note on the occasion of the Identifier’s Day that is marked this Wednesday, the ministry points that 12.2 million Angolans have ID, being that in 2021 were issued 2.5 million IDs.

“The time is for reflection on the activities that were already carried out in the scope of the citizenship attribution to all Angolans”, stresses the document.

Source: Angola Press News Agency

Famous Australian Skin Cancer Ad Returns to the Airwaves

On the 40th anniversary of a famous skin cancer campaign, research has revealed that a high number of young Australians are not using sun protection.

Australia has one of the highest rates of skin cancer in the world. A new multi-million-dollar awareness campaign hopes to repeat the success of the ‘Slip Slop Slap’ advertisement of the early 1980s.

“Sid the seagull” the voice of the advertisement’s jingle, urged Australians to protect themselves from the sun with a shirt, sunscreen and a hat. It is an enduring message that has educated generations of people since it was released 40 years ago.

But the government believes rates of skin cancer are too high. The disease kills about 1,300 Australians each year. Research has shown that more than a quarter of Australians do not use any protection from the sun’s ultra-violet radiation.

Heather Walker, from the charity, the Cancer Council, says teenagers need to be reminded of the sun’s dangers.

“We do have a lot of work to do particularly in the secondary school setting and with young adults. But encouragingly, older adults are using sun protection more. So, it does seem to be a dip in the lifecycle and then people do come back to sun protection, which is really encouraging. But the other group that needs a reminder in particular is men. So, in Australia twice as many men as women die from melanoma and that is a huge disparity,” Walker said.

Now, Australia is launching the first national skin cancer campaign in more than a decade. Sid the seagull’s famous ‘slip, slop, slap’ message has been updated to encourage Australians to also seek shade and slide on a pair of sunglasses.

Health authorities have said that skin cancer is Australia’s most common cancer, and it is almost entirely preventable.

The World Cancer Research Fund states that Australia has the highest melanoma rates in the world followed by New Zealand, Norway and Denmark. It is expected that 16,000 Australians will be diagnosed this year with melanoma, a malignant tumor associated with skin cancer, according to government figures.

The Australian Cancer Council lists three main types of skin cancers: basal cell carcinoma, squamous cell carcinoma and melanoma.

Source: Voice Of America

Biden Touts Deal Delaying 5G Rollout by AT&T, Verizon

President Joe Biden touted an agreement Tuesday between wireless carriers and U.S. regulators to allow the deployment of 5G wireless technology in two weeks.

AT&T and Verizon said Monday they would delay activating the new service for two weeks following a request by Transportation Secretary Pete Buttigieg. He cited airline industry concerns that the technology’s rollout could interfere with sensitive electronic systems on aircraft and disrupt thousands of daily flights.

The telecommunications giants’ announcement came one day after they maintained they would not postpone the introduction of the service. But they agreed to the delay amid pressure from the White House and aviation unions, and concerns expressed by the U.S. Federal Aviation Administration.

Biden said in a statement Tuesday the “agreement ensures that there will be no disruptions to air operations over the next two weeks and puts us on track to substantially reduce disruptions to air operations when AT&T and Verizon launch 5G on January 19th.”

In an email Tuesday to employees, Verizon Chief Executive Hans Vestberg said the company saw no aviation safety issue with 5G, but added the FAA “intended to disrupt an already difficult time for air travel if we move ahead with our planned activation… We felt that it was the right thing to do for the flying public, which includes our customers and all of us, to give the FAA a little time to work out its issues with the aviation community.”

Buttigieg and FAA Administrator chief Steve Dickson said in a letter sent Monday to AT&T and Verizon that the agencies would not seek any further delays beyond January 19 if there are not any “unforeseen aviation safety issues,” according to Reuters.

The letter also reportedly said the agreement “will give us additional time and space to reduce the impacts to commercial flights.”

Source: Voice Of America

Lower Cassanje massacre survivors demand better conditions

Cahombo – Survivors and descendants of the martyrs of the colonial repression in Lower Cassanje today demanded the improvement of social conditions of the region as a way of valorising the heroes of this historical action, which dictated the independence of the country in 1975.

61 years after the massacre of Cassanje, some of the participants defend more efforts for the improvement of the quality of life of the population, which is struggling with several difficulties.

Interviewed on the occasion of 4 January (Day of the Martyrs of Colonial Repression), the interlocutors called for the extension of the school and hospital network, as well as of the energy and water services.

According to the chief Manuel Kituxe Zaje “Yalanguela”, from Quela municipality, it is imperative to bet on the welfare of the population of Lower Cassanje to reverse the current situation, characterised by the lack of social services.

On 4 January 1961, peasants of the cotton fields of Cassanje in northern Malanje province were murdered for protesting against the low prices of cotton bought by the oppressive regime. The response was bombing by the Portuguese Air Force, which claimed the lives of thousands of people.

Covering 80 square kilometres, the Lower Cassanje comprises the provinces of Malanje, Lunda Norte and Lunda Sul.

Source: Angola Press News Agency

Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus

– Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand

– ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection

– ASC11 is an oral direct-acting antiviral drug candidate targeting 3-chymotrypsin like protease (3CLpro), combined with ritonavir oral tablets, to treat SARS-CoV-2 infection

HANGZHOU and SHAOXING, China, Jan. 3, 2022 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672) today announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2 infection. The Company’s COVID-19 pipeline currently includes (i) ritonavir oral tablet (100mg), an authorized product, (ii) ASC10, an oral RNA dependent RNA polymerase (RdRp) inhibitor and (iii) ASC11, an oral 3-chymotrypsin like protease (3CLpro) inhibitor.

The Company owns the only authorized ritonavir oral tablet in China, which passed bioequivalence study. The Company’s ritonavir oral tablet was approved in September, 2021 by China National Medical Products Administration (NMPA). As a pharmacokinetic booster of multiple antiviral protease inhibitors, a low dose ritonavir oral tablet (100mg) is a component of oral direct-acting antiviral drug Paxlovid (Nirmatrelvir+ritonavir). The Company applied the sophisticated formulation technology to significantly increase the human bioavailability of ritonavir which has a very poor solubility and successfully achieved human bioequivalence with the ritonavir oral tablets produced by the Originator, AbbVie. The Company is planning to file generic drug applications for registrations in multiple countries in the world. Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand.

ASC10 is an oral direct-acting antiviral drug candidate targeting RdRp. In vitro data showed significant activity against SARS-CoV-2. ASC10 is an in-house discovered drug candidate with the global intellectual property and commercial rights. Compared to RdRp-targeted Molnupiravir which was approved by US Food and Drug Administration (FDA), ASC10 has a new and differentiated chemical structure. The Company has filed multiple compound and use patent applications. The data from animal studies demonstrated that ASC10 has higher bioavailability when compared to Molnupiravir. The Company plans to submit investigational drug applications (INDs) for clinical trials in China, USA etc. in the first half of 2022.

ASC11 is an oral direct-acting antiviral drug candidate targeting 3CLpro, in combination with the authorized ritonavir oral tablets produced by the Company, to treat SARS-CoV-2 infection. ASC11 is an in-house discovered drug candidate with the global intellectual property and commercial rights. Compared to 3CLpro-targeted Nirmatrelvir which was approved by US FDA, ASC11 has a new and differentiated chemical structure. The Company has filed the compound and use patent applications. The Company plans to submit INDs for clinical trials in China, USA etc. in the second half of 2022. The Company has extensive R&D experience in viral protease inhibitors and successfully developed and commercialized oral HCV protease inhibitor GANOVO® in combination with ritonavir oral tablets for the treatment of chronic hepatitis C.

“At the beginning of COVID-19 in 2020, based on its antiviral platform and R&D experience, the Company made the firm and rapid decision to invest in oral direct-acting antivirals R&D against RdRp and 3CLpro of SARS-CoV-2. Meanwhile, the Company accelerated the development effort to obtain the approval of ritonavir oral tablets in China and successfully achieved the authorization by China NMPA for ritonavir oral tablets,” said Dr. Jinzi J. Wu, Founder, Chairman and CEO of Ascletis, “The Company has tremendous experience in antiviral oral protease inhibitors and successfully developed the fixed-dose combination ASC09F (ASC09+ritonavir) to treat HIV infection, in addition to launching GANOVO®/Ritonavir combination for chronic hepatits C.”